NCT01728701View on ClinicalTrials.gov

Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
MalariaPlasmodium Falciparum
Interventions
BIOLOGICAL

PfSPZ Challenge

PfSPZ Challenge is a suspension of aseptic, purified, cryopreserved PfSPZ that are thawed and formulated in diluent on the day of administration.

BIOLOGICAL

Normal Saline (NS)

Normal saline

Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

lead

Sanaria Inc.

INDUSTRY

NCT01728701 - Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis | Biotech Hunter | Biotech Hunter